Publications & Reports

Evaluation of the Cavidi ExaVir Load assay (version 3) for plasma human immunodeficiency virus type 1 load monitoring.

Greengrass VL, Plate MM, Steele PM, Denholm JT, Cherry C, Morris LM, Hearps A, Crowe SM
Clinical Research Laboratory, Centre for Virology, Macfarlane Burnet Institute for Medical Research and Public Health, 85 Commercial Road, Melbourne, Australia.


We evaluated the new low-cost ExaVir Load (version 3) reverse transcriptase viral load assay against the Roche Cobas Amplicor assay. Results for samples tested using the reverse transcriptase assay correlated well with those obtained with the Roche assay (r = 0.85; n = 202). The version 3 reverse transcriptase assay shows improved sensitivity compared to the previous version.


  • Journal: Journal of Clinical Microbiology
  • Published: 01/09/2009
  • Volume: 47
  • Issue: 9
  • Pagination: 3011-3013